A potential synbiotic product improves the lipid profile of diabetic rats

Lipids in Health and Disease

Volumn 11, Issue , 2012, Pages

  Roselino, Mariana N ^a   Pauly Silveira, Nadiége D ^a   Cavallini, Daniela C U ^a   Celiberto, Larissa S ^a   Pinto, Roseli A ^a   Vendramini, Regina C ^a   Rossi, Elizeu A ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Blood glucose; Diabetes mellitus; Fermented soy product; Lipid profile; Prebiotics; Probiotics

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; NATURAL PRODUCT; PLANT EXTRACT; PROBIOTIC AGENT; SMALLANTHUS SONCHIFOLIUS EXTRACT; SYMBIOTIC PRODUCT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CELL VIABILITY; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; ENTEROCOCCUS FAECIUM; ENZYME ACTIVITY; EXPERIMENTAL MODEL; FERMENTED PRODUCT; FLUID INTAKE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; LACTOBACILLUS HELVETICUS; MALE; NONHUMAN; RAT; SMALLANTHUS SONCHIFOLIUS; SOYBEAN; STREPTOZOCIN DIABETES;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; ENTEROCOCCUS FAECIUM; FERMENTATION; LACTOBACILLUS HELVETICUS; LIPIDS; MALE; PLANT EXTRACTS; RATS; RATS, WISTAR; SOYBEANS; SYNBIOTICS;

ANIMALIA; ENTEROCOCCUS FAECIUM; GLYCINE MAX; GREAT ISLAND VIRUS; LACTOBACILLUS HELVETICUS; POLYMNIA SONCHIFOLIA; RATTUS;

EID: 84865957500     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-11-114     Document Type: Article

References (65)

1. Financing the care of diabetes mellitus in the U.S. Bransome ED, Diabetes Care 1992 15 1 5 10.2337/diacare.15.1.1 1547697
2. Diabetes melito: plantas e princípios ativos naturais hipoglicemiantes. Negri G, Revista Brasileira de Ciências Farmacêuticas 2005 41 2 121 142 20863933
3. Robbins SL, Cotran RS, Kumar V, Taranto G, Patologia estrutural e funcional Rio de Janeiro: Guanabara Kogan 4 1991 817 826
4. Insulin and other antidiabetic agents. Shoelson SE, Kirk-Othmer encyclopedia of chemical technology New York: John Wiley 3 1995 662 676
5. Berne RM, Genuth SM, Fisiologia Rio de Janeiro: Guanabara Koogan 4 2000 190
6. Pâncreas Endócrino. Godoy P, Patologia Rio de Janeiro: Guanabara Koogan, Bogliolo L, 6 2000 1004 1008
7. Ethnopharmacological survey of medicinal herbs in Israel, the Golan heights and the West Bank Region. Said O, Khalil K, Fulder S, Azaizeh H, J Ethnopharmacol 2002 3 251 265
8. Temporal response pattern of biochemical analytes in experimental diabetes. Mori DM, Baviera AM, De Oliveira RLT, Vendramini RC, Brunetti IL, Pepato MT, Biotechnol Appl Biochem 2003 38 183 191 10.1042/BA20030034 12826018
9. Colesterol e composição dos ácidos graxos nas dietas para humanos e na carcaça suínas. Ludke MC, López J, Ciência Rural 1999 29 1 181 187 10.1590/S0103-84781999000100033 23162861
10. Impacto f traditional risk factors. Armaganijan D, Batlouni M, Revista da sociedade de cardiologia do Estado de São Paulo São Paulo: Edson Stefanini, SOCESP 10 2000 689 693
11. Lipids, lipoproteins, apolipoproteins, and other cardiovascular risk factors. Rifai N, Warnick GR, Tietz textbook of clinical chemistry and molecular diagnostics St. Louis: Elsevier Saunders, Burtis CA, Ashwood ER, Bruns DE, 40 2006 903 981
12. Evaluation of health and nutritional properties in food including powder milk with live lactic acid bacteria. FAO/WHO, Expert consultation report Cordoba 2011 http://www.fao.org/es/ESN/Probio/probio.htm
13. Desenvolvimento e avaliação biológica do potencial hipocolesterolêmico de um novo produto probiótico de soja. Rossi ER, Tese (livre docência)-faculdade de ciências farmacêuticas Araraquara: Universidade Estadual Paulista 2000
14. Effects of a novel soy product on the serum lipids of hypercholesterolemic rabbits. Rossi EA, Vendramini RC, Carlos IZ, Ueiji IS, Squinzari MM, Silva Junior SI, Valdez GF, Arq Bras Cardiol 2000 74 213 216 10.1590/S0066-782X2000000300003
15. Efeito de um novo produto fermentado de soja sobre os lípides séricos de homens adultos normocolesterolêmicos. Rossi EA, Vendramini RC, Carlos IZ, Oliveira MG, Valdez GF, Arq Latin Nutr 2003 53 47 51
16. Determinação de isoflavonas nas diversas etapas do processamento de iogurte de soja. Rossi EA, Rosier I, Dâmaso AR, Carlos IZ, Vendramini RC, Abdalla DSP, Talarico VH, Minto DF, Alim Nutr 2004 15 2 93 99
17. Fermented soy product supplemented with isoflavones affects adipose tissue in a regional-speccific manner and improves HDLcholesterol in rats fed on a cholesterol-enriched diet. Manzoni MSJ, Rossi EA, Carlos IZ, Vendramini RC, Duarte ACGO, Tenorio NM, Amorim DB, Damaso AR, Eur Food Res Technol 2008 227 6 1591 1597 10.1007/s00217-008-0883-1
18. Zumo de yacón-ficha técnica. Rivera D, Manrique, Centro internacional de la Papa (CIP) Lima: Disponível em 2005 http://www.cipotato.org/artc/cipcrops/fichazumoyacon.pdf
19. Hipoglycemic effect of the water extract of smallantus sonchifolius (yacon) leaves in normal and diabetic rats. Aybar MJ, Sánchez Riera AN, Grau A, Sánchez SS, J Ethnopharmacol 2001 74 2 125 132 10.1016/S0378-8741(00)00351-2 11167030
20. Effects of consumption of probiotics and prebiotics on serum lipid levels in humans. Pereira D, Gibson GR, Critical Rev Biochem Molec Biol 2002 37 4 259 281 10.1080/10409230290771519
21. Antidiabetic effects of an oral administration of lactobacillus casei in a non-insulin-dependent diabetes mellitus (NIDDM) model using KK-Ay mice. Matsuzaki T, Yamazaki R, Hashimoto S, Yokokura T, Endocr J 1997 44 357 365 10.1507/endocrj.44.357 9279510
22. Effect of oral administration of lactobacillus casei on alloxan-induced diabetes in mice. Matsuzaki T, Nagata Y, Kado S, Uchida K, Hashimoto S, Yokokura T, APMIS 1997 105 637 642 10.1111/j.1699-0463.1997.tb05065.x 9298103
23. Antidiabetic effect of lactobacillus GG in streptozotocin-induced diabetic rats. Tabuchi M, Ozaki M, Tamura A, Yamada N, Ishida T, Hosoda M, Hosono A, Biosci Biotechnol Biochem 2003 67 1421 1424 10.1271/bbb.67.1421 12843677
24. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Cani PD, Neyrinck AM, Fava F, Knauf C, Burcelin RG, Tuohy KM, Gibson GR, Delzenne NM, Diabetologia 2007 50 2374 2383 10.1007/s00125-007-0791-0 17823788
25. Antidiabetic effect of probiotic dahi containing lactobacillus acidophilus ans lactobacillus casei in high fructose fed rats. Yadav H, Jain S, Sinha PR, Nutr 2007 23 62 68 10.1016/j.nut.2006.09.002
26. Effect of lactobacillus gasseri BNR17 on blood glucose levels and body weight in a mouse model of type 2 diabetes. Yun SI, Park HO, Kang JH, J Appl Microbiol 2009 107 5 1681 1686 10.1111/j.1365-2672.2009.04350.x 19457033
27. The improvement of hypertension by probiotics: effects on cholesterol, diabetes, renin and phytoestrogens. Lye HS, Kuan CY, Ewe JA, Fung WY, Liong MT, Int J Mol Sci 2009 10 3755 3775 10.3390/ijms10093755 19865517
28. Efeito da ingestão de um produto de soja fermentado com enterococcus faecium e lactobacillus helveticus. Vendramini AP, Dissertação (mestrado em análises clínicas)-faculdade de ciências farmacêuticas Araraquara: Universidade Estadual Paulista 2002
29. Efeito de um novo produto fermentado de soja, enriquecido com isoflavonas e cálcio, sobre o tecido ósseo de ratas. Bedani R, Rossi EA, Lepera JS, Wang CC, Valdez GF, Arc Latinoam Nutr 2006 56 146 152
30. Isoflavone-supplemented soy yoghurt associated with resistive physical exercise increase bone mineral density of ovariectomized rats. Shiguemoto GE, Rossi EA, Baldissera V, Gouveia CH, Valdez GMF, Perez SEA, Maturitas 2007 57 261 270 10.1016/j.maturitas.2007.01.011 17368767
31. Intake of isoflavone-supplemented soy yogurt fermented with enterococcus faecium lowers serum total cholesterol and non-HDL cholesterol of hypercholesterolemic rats. Rossi EA, Cavallini DCU, Carlos IZ, Vendramini RC, Dâmaso AR, Valdez GF, Eur Food Res Technol 2008 228 2 275 282 10.1007/s00217-008-0932-9
32. Efeito do iogurte de soja fermentado com E. faecium e suplementado com isoflavonas nos marcadores laboratoriais de risco cardiovascular e na aterosclerose. Cavallini DCU, 140f. relatório (pós-doutorado)- faculdade de ciências farmacêuticas Araraquara: UNESP 2009
33. O emprego da metodologia de resposta no desenvolvimento de um novo produto simbiótico, fermentado com enterococcus faecium CRL 183 e lactobacillus helveticus ssp jugurti 416, à base de extratos aquosos de soja e de yacon (smallanthus sonchifolius). Pauly-Silveira ND, UNESP, dissertação (mestrado em alimentos e nutrição- área de ciência dos alimentos)-faculdade de ciências farmacêuticas Araraquara-SP: Universidade Estadual Paulista 2009 23158329
34. Localization of glycogen in the placenta and fetal and maternal livers of cadmium exposed diabetic pregnant rats. Yoruk M, Kanter M, Meral I, Agaoglu Z, Biol Trace Elem Res 2004 96 217 226
35. Effects of cadmium exposure on morphological aspects of pancreas, weights of fetus and placenta in streptozotocin-induced diabetic pregnant rats. Kanter M, Yoruk M, Koc A, Meral I, Karaca T, Biol Trace Elem Res 2003 93 189 200 10.1385/BTER:93:1-3:189 12835501
36. Fructan and free fructose content of common Australian vegetables and fruit. Muir JG, Shepherd SJ, Rosella O, Rose R, Barrett JS, Gibson PR, J Agric Food Chem 2007 55 16 6619 6627 10.1021/jf070623x 17625872
37. Experimental alloxan diabetes induced: a model for clinical and laboratory studies in rats. Lerco MM, Spadella CT, Machado JLM, Schellini SA, Padovani CR, Acta Cir Bras 2003 18 2 132 142 [online]
38. Determination of glucose in blood using glucose with alternative oxygen acceptor. Trinder R, Ann Clin Biochem 1969 6 27 27
39. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, Mcdonald JM, Parrot M, Clin Chem 2002 48 436 472 11861436
40. Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes: the strong heart study. Lu W, Resnick HE, Jablonski KA, Jones KL, Jain AK, Howard WJ, Robbins DC, Howard BV, Diabetes Care 2003 26 1 16 23 10.2337/diacare.26.1.16 12502653
41. Growth of bifidobacteria and their enzyme profiles. Desjardins ML, Roy D, Goulet J, J Dairy Sci 1990 73 299 307 10.3168/jds.S0022-0302(90)78673-0
42. Position of the American dietetic association: functional foods. ADA (American Dietetic Association), J Am Diet Assoc 1999 99 1278 1285 10524397
43. Produção com tratamento enzimático e avaliação do suco de yacon. Quinteros ETT, Tese (doutorado em tecnologia de alimentos)-faculdade de engenharia de alimentos Campinas: Universidade Estadual de Campinas 2000
44. Hypoglycemic activity of leaf organic extracts from smallanthus sonchifolius: constituents of the most active fractions. Genta SB, Cabrera WM, Mercado MI, Grau A, Catalán CA, Sánchez SS, Chem Biol Interact 2010 185 2 143 152 10.1016/j.cbi.2010.03.004 20211156
45. Anti-diabetes constituents in leaves of smallanthus sonchifolius. Xiang Z, He F, Kang TG, Dou DQ, Gai K, Shi YY, Kim YH, Dong F, Nat Prod Commun 2010 5 1 95 98 20184030
46. Appearance of different diabetic symptoms after streptozocin administration: a comparison study. Wong KK, Tzeng ES, Biochem Mol Biol Int 1993 30 1035 1041 8220250
47. Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. Meigs JB, Hu FB, Rifai N, Manson JE, J Am Med Assoc 2004 291 16 1978 1986 10.1001/jama.291.16.1978
48. Frutooligossacarídeos: implicações na saúde humana e utilização em alimentos. Passos LML, Park YK, Ciência Rural 2003 33 2 385 390 10.1590/S0103-84782003000200034 23162861
49. Anti-hyperglycemic effect of eugenia jambolana and tinospora cordifolia in experimental diabetes and their effects on key metabolic enzymes involved in carbohydrate metabolism. Grover JK, Vats V, Rathi SS, J Ethnopharmacol 2000 73 3 461 470 10.1016/S0378-8741(00)00319-6 11091000
50. Studies on the diabetogênico action of streptozotocin. Rakieten N, Rakieten L, Nadkarni M, Cancer Chemother Rep 1963 29 91 98 13990586
51. O efeito da insulina sobre concentrações glicêmicas e lipídicas em ratos normais e diabéticos induzidos pela estreptozotocina. Maffezzoli AS, Trabalho de conclusão de curso Santa Catarina: Universidade do Vale do Itajaí, UNIVALI 2004
52. A raiz yacon (smallanthus sonchifolius poepping & endlicher) como fonte de fibras alimentares, sua caracterização físico-quimica, uso na panificação e sua influência na glicemia pós-prandial. Silva ADS, Tese (doutorado)-departamento de ciência e tecnologia de alimentos Florianópolis: Universidade Federal de Santa Catarina 2007 17160316
53. Amelioration of streptozotocin-induced diabetes mellitus, oxidative stress and dyslipidemia in rats by tomato extract lycopene. Ali MM, Agha FG, Scand J Clin Lab Invest 2009 69 3 371 379 10.1080/00365510802658473 19148834
54. Effect of crude extracts of leaves of smallanthus sonchifolius (yacon) on glycemia in diabetic rats. Baroni S, Kemmelmeier FS, Caparroz-Assef SM, Cuman RKN, Bersani-Amado CA, Braz J Pharma Sci 2008 44 3 521 530
55. Probiotics: potential pharmaceutical applications. Kaur IP, Chopra K, Saini A, Eur J Pharma Sci 2002 15 1 9 10.1016/S0928-0987(01)00209-3
56. Prophylactic and therapeutic uses of probiotics: a review. Koop-Hoolihan L, J Am Diet Assoc 2001 101 229 238 10.1016/S0002-8223(01)00060-8 11271697
57. Diabetes e hipertensión aspectos clínicos y terapêuticos. Contreras F, Rivera M, Vásquez JF, YáneZ CJB, De La Parte MA, Velasco M, Arch Vzlanos Farmacol Terap 2000 19 9 24
58. Avaliação do potencial alergênico de um novo produto fermentado de soja. Rossi EA, Carlos IZ, Vendramini RC, Machado CO, Cyrillo RNS, Perazzo FF, Valdez GF, RBCF Ver Brás Ciênc Farm São Paulo 2000 21 1 103 113
59. Binding of free bile acids by cells of yogurt starter culture bacteria. Pigeon RM, Cuesta EP, Gilliland SE, J Dairy Sci 2002 85 2705 2710 10.3168/jds.S0022-0302(02)74357-9 12487437
60. Acid and bile tolerance and the cholesterol removal ability of bifidobacteria strains. Liong MT, Shah NP, Biosci Micro 2005 24 1 10
61. Roles of probiotics and prebiotics on cholesterol: the hypothesized mechanisms. Liong MT, Shah NP, Nutrafoods 2005 4 45 57
62. Effect of bifidobacterium and lactobacillus acidophilus in diabetic rats. Khamisy AESE, The 5th Arab and 2nd international: annual scientific conference Egypt: Faculty Specific Education-Mansoura University 2010 2425 2439
63. Selection and optimization procedure of symbiotic for cholesterol removal. Zhang F, Xiaomim H, Xiaobing F, Guije L, Hong Y, Anaerobe 2007 13 185 192 10.1016/j.anaerobe.2007.06.001 17681806
64. Longterm consuption of fermented dairy products over 6 months increases HDL cholesterol. Kiebling G, Schneider J, Jahreis G, Eur J Clin Nutr 2002 56 843 849 10.1038/sj.ejcn.1601399 12209372
65. Probiotic capsules do not lower plasma lipids in young women and men. Greany KA, Bonorden MJ, Hamilton-Reeves JM, McMullen MH, Wangen KE, Phipps WR, Feirtag J, Thomas W, Kurzer MS, Eur J Clin Nutr 2008 62 232 237 10.1038/sj.ejcn.1602719 17356554